Martek profits hold as customers downsize omega-3 stocks
Martek Biosciences Corporation has almost matched its Q3 profit results from 2008, despite sales falling 12 per cent, as cost-cutting measures and productivity gains have bolstered its results despite dwindling customer stock levels.